Atlas Trials

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Clinical trial NCT01696461 · COMPLETED

Trial details

NCT number
NCT01696461
Sponsor
Center for International Blood and Marrow Transplant Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeChronic Myelogenous LeukemiaNon-Hodgkin's LymphomaHodgkin's DiseaseChronic Lymphocytic Leukemia
Start date
2013-05-01
Primary completion
2016-08-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.